Boston University Amyloidosis Center — Boston, Massachusetts

Boston University Amyloidosis Center is a clinical research site located in Boston, Massachusetts, United States 02118.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Boston University Amyloidosis Center has participated in 1 clinical trials.

Therapeutic areas: Diffuse Cutaneous Systemic Sclerosis.

Sponsors: CSL Behring.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston University Amyloidosis Center?

Boston University Amyloidosis Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston University Amyloidosis Center conducted?

Boston University Amyloidosis Center has 1 clinical trials on record. Their work covers Diffuse Cutaneous Systemic Sclerosis.

Is Boston University Amyloidosis Center accredited by Crixeo Health?

Boston University Amyloidosis Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston University Amyloidosis Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.